Quillivant XR 25 MG/5 ML susp 120ML
Ended Awarded
- Contract number
- SPE2DB25FAWJT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,218
Award facts
- Contract value 100% obligated
- $2,217.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) with a ceiling value of $2,217.66. The award, finalized on September 10, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 11, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order was issued without a set-aside designation, allowing the contractor to compete on equal footing in the federal procurement marketplace.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026. The parent contract, executed under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Quillivant XR, a branded ADHD medication, falls within the contractor's established portfolio of prescription drugs and specialty medications that serve military health systems. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent performance of similar delivery orders across diverse medication categories.
Quick answers
Who was awarded contract SPE2DB25FAWJT?
SPE2DB25FAWJT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FAWJT worth?
The government has obligated $2,218 on SPE2DB25FAWJT.
Is contract SPE2DB25FAWJT an order under another contract?
Yes. SPE2DB25FAWJT is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWJT competed?
The extent of competition for SPE2DB25FAWJT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award